Sven Arne Andréasson
Director/Board Member bij MENDUS AB
Vermogen: - $ op 29-02-2024
Profiel
Sven Arne Andréasson is a businessperson who has been at the head of 12 different companies and occupies the position of Chairman for Operations Leadership Oil AB.
He is also on the board of Mendus AB, Cellastra, Inc. and Galenos Sprl and Deputy Director at Stefan Forsberg Consulting AB.
In the past Mr. Andréasson was Chairman of Unibioscreen SA, Chairman for Cantargia AB, Co-Chief Executive Officer for Active Biotech AB, Chief Executive Officer at Beta-Cell NV, President for Kabi Pharmacia, President at Pharmacia Arzneimittel GmbH, President of Kabipharmacia International, Senior Vice President-Corporate Development of Novavax, Inc. and Chief Executive Officer at Novavax AB (a subsidiary of Novavax, Inc.), Chief Executive Officer-Biopharma Division at Kabivitrum AB, President & Vice President at Pharmacia AB, President of Pharmacia SAS and President for Sista versen 26366 AB.
Sven Arne Andréasson received an undergraduate degree from Stockholm School of Economics.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-12-2022 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Sven Arne Andréasson
Bedrijven | Functie | Begin |
---|---|---|
MENDUS AB | Director/Board Member | 01-01-2020 |
Stefan Forsberg Consulting AB | Corporate Officer/Principal | - |
Galenos SRL | Director/Board Member | 01-01-2014 |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Director/Board Member | - |
Operations Leadership Oil AB | Chairman | 15-10-2010 |
Eerdere bekende functies van Sven Arne Andréasson
Bedrijven | Functie | Einde |
---|---|---|
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Director/Board Member | 23-06-2023 |
NOVAVAX, INC. | Corporate Officer/Principal | 01-05-2023 |
MENDUS AB | Director/Board Member | 26-05-2016 |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Chief Executive Officer | 01-11-2013 |
░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Sven Arne Andréasson
Stockholm School of Economics | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
NOVAVAX, INC. | Health Technology |
ACTIVE BIOTECH AB | Health Technology |
CANTARGIA AB | Health Technology |
MENDUS AB | Health Technology |
Bedrijven in privébezit | 19 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Pharmacia AB | Health Technology |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
Pharmacia SAS | |
Kabi Pharmacia | |
Kabivitrum AB | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Beta-Cell NV
Beta-Cell NV Miscellaneous Commercial ServicesCommercial Services Beta-Cell NV is a Belgian company that offers a cell replacement therapy for diabetes. The private company is based in Brussels, Belgium. The company's therapy provides a cure for diabetes, which affects people of all ages, genders, and ethnicities. | Commercial Services |
Operations Leadership Oil AB | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
Galenos SRL | |
Stefan Forsberg Consulting AB | |
Advet AB | |
Advet Production AB | |
Pharmacia Arzneimittel GmbH
Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Pharmacia Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ratingen, Germany. | Health Technology |
Kabipharmacia International
Kabipharmacia International Pharmaceuticals: MajorHealth Technology Kabipharmacia International is a French company that manufactures pharmaceutical products. | Health Technology |